Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?
Diamandis
Eleftherios P
EP
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5 Canada. ediamandis@mtsinai.on.ca
D014408:Biomarkers, Tumor / Q000032:analysis*; D001826:Body Fluids / Q000737:chemistry*; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D009369:Neoplasms / Q000175:diagnosis*; D010455:Peptides / Q000097:blood; D011467:Prostate / Q000737:chemistry; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis; D040901:Proteomics; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor; D010455:Peptides; D017430:Prostate-Specific Antigen